Isolation precautions cause minor delays in diagnostics and treatment of non-COVID patients

Paajanen, Juuso; Mäkinen, Laura K.; Suikkila, Anna; Rehell, M.; Javanainen, Mervi; Lindahl, Anna; Kekäläinen, Eliisa; Kurkela, Satu; Halmesmäki, Karoliina; Anttila, Veli‐Jukka; Lamminmäki, Satu

doi:10.1016/j.infpip.2021.100178

Cited by 3 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients in isolation might have experienced more delays or cancellations of diagnostic tests compared with patients who were not isolated. In the population of the study by Paajanen et al, 8 5 patients (15%) experienced a treatment delay, 5 (15%) experienced a diagnosis delay, and 23 (70%) experienced both. Seven patients (1.0%) showed health deterioration during isolation.…”

Section: Discussionmentioning

confidence: 92%

Identifying Adverse Events in Patients Hospitalized in Isolation or Quarantine Due to COVID-19

et al. 2023

View full text Add to dashboard Cite

Background: This study evaluated the adverse events of COVID-19 isolation or quarantine in patients with nosocomial SARS-CoV-2 infection admitted to the Hospital Universitario Insular de Gran Canaria.Methods: This is a retrospective cohort study with 30-day follow-up of 126 patients diagnosed with nosocomial COVID-19 through polymerase chain reaction test, between May 1 and June 30, 2022, in a 500-bed university hospital in the island of Gran Canaria.Results: Between May 1 and July 30, 2022, a total of 2250 patients were admitted to the Hospital Universitario Insular de Gran Canaria; 126 of them were diagnosed with nosocomial COVID-19 through a polymerase chain reaction test. The rate of nosocomial COVID-19 infection was 5.6%. From the 126 patients of the study population, 27 experienced an adverse event (21.4%) and 2 experienced 2 adverse events (1.6%) due to COVID-19 isolation or quarantine. Thus, a total of 31 adverse events occurred in 29 patients. These events included the following: delay in transfer to other centers of 11 patients who were pending of receiving a negative COVID-19 test result (35.5%), delay or cancellation of diagnostic tests in 9 patients (29%), delay or cancellation of doctor visit in 7 patients (22.6%), and delay or cancellation of surgical or other interventions in 4 patients (12.9%).Conclusions: Because of the adverse consequences of nosocomial COVID-19 infection in hospitalized patients, measures should be observed for the prevention and control of nosocomial infection transmission, and adverse events related to patient safety issues in health care in isolated or quarantined COVID-19 patients should be prevented.

show abstract

Section: Discussionmentioning

confidence: 92%

Identifying Adverse Events in Patients Hospitalized in Isolation or Quarantine Due to COVID-19

et al. 2023

View full text Add to dashboard Cite

show abstract

COVID‐19 pandemic impact on gynecologic cancer treatment pathways in a Finnish tertiary center

Pikkujämsä,

Luukkaala,

Nyberg

et al. 2024

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

IntroductionCOVID‐19 and new guidelines during the pandemic affected the gynecologic cancer treatment pathways, resulting in recorded delays and modifications in the treatment protocols. The aim of this study was to determine the impact of the COVID‐19 pandemic in one of the major gynecologic cancer care centers in Finland, Tampere University Hospital.Material and MethodsOur retrospective register study included 909 patients that were new gynecologic cancer cases (uterine, cervical, vulvar, vaginal, or ovarian) referred to the Tampere University Hospital Gynecologic Oncology Outpatient Clinic between March 17th, 2018, and March 15th, 2022. The patients were divided into two separate groups depending on their time of referral: time before COVID (March 17th, 2018, to March 15th, 2020), and during COVID (March 16th, 2020, to March 15th, 2022). These groups were compared in terms of patient characteristics, different cancer types and stages, symptoms, and treatment methods.ResultsDuring the COVID‐19 pandemic, patients generally suffered from cancer symptoms longer (p < 0.003) and were more likely to be overweight (p = 0.035). The improved multidisciplinary team meeting gave the patients a faster route to their first intervention during COVID (p < 0.05). An insignificant shift toward nonsurgical first interventions and non‐curative intent was seen during COVID, but the multidisciplinary team treatment plans were mostly implemented accordingly on both eras. No decrease was seen in the number of new gynecologic cancer cases, and the one‐year overall survival remained the same in both groups.ConclusionsOverall, the COVID‐19 pandemic did not significantly alter treatment pathways in gynecologic cancer care at Tampere University Hospital. The number of new patients and given treatments remained relatively stable. During COVID, access from referral to cancer treatment was significantly accelerated, which is likely confounded by changes to the multidisciplinary team protocol made in early 2021.

show abstract

Ten-Year Trends in Otolaryngological Surgery Volumes and the Impact of Infection Prevention During the COVID-19 Pandemic—A National Study

Valajärvi,

Lamminmäki,

Lundberg

et al. 2024

JCM

View full text Add to dashboard Cite

Background/Objectives: This register study elucidates the national trends in the otolaryngologic surgery volume in Finland over a ten-year period. In particular, we investigated whether the pandemic, which had a marked effect on communicable diseases, had an impact on infection-related ear, nose, and throat (ENT) procedures. For reference, we used noninfectious ENT procedures. Methods: The data of this study consisted of the volumes of different otolaryngological surgical procedures in Finland from 2012 to 2022. A linear regression model was applied to calculate long-term trends in surgery volumes. The annual predicted and observed surgical volumes of each procedure were compared. In addition, different procedures were compared based on whether they were mostly infection-related, non-infection-related, or both. Results: The results revealed that the pandemic altered the trends of many ENT procedures, and during the pandemic, infection-related surgeries declined more than non-infection-related surgeries did. The decline in infection-related surgery volumes seems to have lasted longer than the coronavirus disease 2019 (COVID-19) pandemic itself, as only tympanostomies and mastoidectomies of all the infection-related procedures included in this study have returned to the pre-pandemic trend. Some non-infection-related procedures and procedures with mixed indications also declined during the pandemic and sustained their reduction even in 2022. Conclusions: This study provides a nationwide insight into ENT surgery volumes in Finland over a ten-year period. Although causative reasoning cannot be conducted based on this study, it still provides a good indication of how the absence of respiratory viruses and multifactorial societal restriction measures could have a long-lasting effect on the epidemiology and management of many ENT diseases.

show abstract

Isolation precautions cause minor delays in diagnostics and treatment of non-COVID patients

Cited by 3 publications

References 24 publications

Identifying Adverse Events in Patients Hospitalized in Isolation or Quarantine Due to COVID-19

Identifying Adverse Events in Patients Hospitalized in Isolation or Quarantine Due to COVID-19

COVID‐19 pandemic impact on gynecologic cancer treatment pathways in a Finnish tertiary center

Ten-Year Trends in Otolaryngological Surgery Volumes and the Impact of Infection Prevention During the COVID-19 Pandemic—A National Study

Contact Info

Product

Resources

About